Wilate
Wilate is a medicine containing clotting factors used to treat and prevent bleeding in patients with von Willebrand disease and Hemophilia A.
Form
injektiokuiva-aine ja liuotin, liuosta varten
Strength
1000 IU VWF / 1000 IU FVIII
Active Ingredient
Factor VIII (antihaemophilic factor)
Manufacturer
Octapharma AB
How to Use
Dosage
Your doctor will determine the dose and how often you should use Wilate. Always use as prescribed by your doctor.
Method
Wilate is dissolved and given as a slow injection into a vein (2-3 ml per minute). Do not mix with other medicines.
Important
Do not use more than the recommended dose. No symptoms of overdose have been reported.
Possible Side Effects
RARE
- •Burning and stinging at the injection site
- •Chills
- •Redness
- •Headache
- •Hives (urticaria)
- •Drop in blood pressure (hypotension)
- •Tiredness (lethargy)
- •Feeling unwell (malaise)
- •Restlessness
- •Fast heartbeat (tachycardia)
- •Shortness of breath
- •Tingling (paraesthesia)
- •Vomiting
- •Wheezing
- •Sudden swelling in different parts of the body (angioedema)
- •Fever
Important Warnings
- Do not use Wilate if you are allergic to its ingredients (von Willebrand factor, Factor VIII, or other substances).
- If you experience signs of an allergic reaction (such as rash, difficulty breathing, or low blood pressure), stop using it immediately and contact your doctor.
- Since Wilate is made from human blood, there is a small risk of infection transmission, even with measures taken to prevent it during manufacturing.
- Pregnant or breastfeeding individuals should consult a doctor before using Wilate, especially due to the risk of parvovirus B19 infection.
- Always record the name and batch number of the Wilate product to track its usage.
Show 2 more warnings
- Some patients may develop antibodies (inhibitors) that prevent the medicine from working. If bleeding does not stop, contact your doctor.
- Wilate treatment can increase Factor VIII levels too much, which might raise the risk of blood clots. Your doctor will monitor this.